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Acetaminophen (APAP) overdose is the principal cause of drug-induced acute liver
failure. 4-hydroxyphenylacetic acid (4-HPA), a major microbiota-derived metabolite of
polyphenols, is involved in the antioxidative action. This study seeks to investigate the
ability of 4-HPA to protect against APAP-induced hepatotoxicity, as well as the putative
mechanisms involved. Mice were treated with 4-HPA (6, 12, or 25 mg/kg) for 3 days,
1 h after the last administration of 4-HPA, a single dose of APAP was intraperitoneally
infused for mice. APAP caused a remarkable increase of oxidative stress markers,
peroxynitrite formation, and fewer activated phase II enzymes. 4-HPA increased Nrf2
translocation to the nucleus and enhanced the activity of phase II and antioxidant
enzymes, and could thereby ameliorate APAP-induced liver injury. Studies reveal that
4-HPA, as an active area of bioactive dietary constituents, could protect the liver against
APAP-induced injury, implying that 4-HPA could be a new promising strategy and natural
hepatoprotective drug.
Keywords: polyphenols, 4-hydroxyphenylacetic acid 4-HPA, acetaminophen APAP, hepatotoxicity, oxidative
stress, nuclear factor erythroid 2-related factor, Nrf2
INTRODUCTION
Acetaminophen (N-acetyl-p-aminophenol, APAP) is a common and effective drug for analgesic
and antipyretic uses. When consumed in overdose quantities, it has high toxicity and leads to
liver failure and acute liver failure (ALF) (Larson et al., 2005). In the United States and the
United Kingdom, high dosing on APAP has been reported as the main reason for drug-induced
liver injury (Blieden et al., 2014). In China, 0.40% drug induced liver injury patients were induced
by APAP (Zhou et al., 2013). APAP undergoes Phase I and II detoxification pathways in the liver;
about 85% of APAP is recovered as APAP-gluc and APAP-sulf by hepatic phase II conjugation
enzymes, including UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs), and
excreted in the urine. It is widely accepted that the highly reactive intermediate of N-acetyl-p-
benzoquinone imine (NAPQI) is metabolized through hepatic phase I reactions by the cytochrome
P-450 (CYP) pathway (primarily by CYP2E1). In the case of an overdose of APAP, the phase II
reaction becomes saturated and the over-production of NAPQI depletes liver glutathione (GSH)
and modifies cellular proteins. This disturbs redox balance and leads to mitochondrial damage and
centrilobular necrosis, which leads to oxidative stress-induced liver injury (James et al., 2003; Xie
et al., 2015).
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It is known that polyphenols, a wealth of secondary plant
metabolites in edible plants, is attributed to a broad spectrum of
bene?cial pharmacological activities in humans (Li et al., 2014).
Evidence indicates that polyphenols were less absorbed in the
small intestine but were accumulated in the colon (Cardona
et al., 2013). A large number of low-molecular-weight phenolic
acids, derived from polyphenols by colonic microflora, could
be absorbed into systemic circulation (Selma et al., 2009; Prior
et al., 2010) and result in bioavailability. Previous publications
have investigated 4-hydroxyphenylacetic acid (4-HPA) as the
major metabolite of proanthocyanidins, kaempferol (Deprez
et al., 2000; Moradi-Afrapoli et al., 2016). 4-HPA possesses
anxiolytic (Vissiennon et al., 2012) and antiplatelet properties
(Kim et al., 1998). In our preliminary work, we investigated the
ability of microbiota-derived metabolites 3,4-HPA of quercetin
to attenuate APAP-induced liver injury in mice (Xue et al.,
2016). These ?ndings suggested that metabolites produced from
polyphenols by intestinal micro?ora might be hepatoprotection
of pharmacologically active compounds. 4-HPA is one of the
major metabolites in polyphenols (Zabela et al., 2016). Molecular
docking study revealed that the position of the hydroxyl group
in 3,4-HPA and 4-HPA have different binding sites on CYP2E1.
The interaction of 4-HPA was comparatively higher than the 3,4-
HPA. 4-HPA docking scores were par with 3,4-HPA acid. It’s
comparatively higher than the standard drug N-acetylcysteine
(Supplementary Material), which indicates the most comfortable
position of ligand in a receptor, compared to both their docking
energy against the Nrf2 and CYP2E1. The results indicate that
4- hydroxyphenylacetic acid has potential to be developed as
hepatocellular carcinoma (HCC) therapy.
MATERIALS AND METHODS
Experimental Setting
Mice were randomly assigned to six groups. The control
group (Control) and negative prevent group (APAP) were
administrated 0.9% saline solution and 300 mg/kg APAP
(Xie et al., 2016), respectively. Clinically, APAP-induced
hepatotoxicity may be attenuated by N-Acetyl-L-cysteine (NAC)
replenishing the GSH store and enhancing hepatic recovery.
However, there are limits to NAC therapy, such as the narrow
therapeutic time window for NAC administration (delayed
treatment may lead to liver injury) (Corcoran and Wong, 1986;
Delanty and Fitzgerald, 1996). NAC could not decrease the
hepatotoxicity at a dose of 25 mg/kg compared to a dose of
100 mg/kg in preliminary experiments. In this study, the positive
prevent group and experimental groups were treated with
N-acetylcysteine (NAC100, 100 mg/kg per day) (Nelson et al.,
2015) or 4-HPA (4HPA6, 4HPA12, 4HPA25, 6, 12, 25 mg/kg
per day) (Sigma, St. Louis, MO, United States), respectively, by
intragastric gavage for three consecutive days. One hour after
the last administration of 4-HPA, NAC, or saline solution, a
single dose of 300 mg/kg APAP was intraperitoneally infused
for mice in the negative control group, positive control group,
and experimental groups. The drugs were dissolved in 0.9%
saline solution immediately before conducting the experiment.
Twenty-four hours after APAP was infused, the mice were
euthanized and harvested for blood and liver tissue samples. The
liver was fixed in 4% para-formaldehyde for histological analysis.
Remaining liver tissue was stored in a deep freezer at −80◦C for
further biochemical analysis.
Serum ALT and AST Assays
Blood samples were centrifuged at 4◦C for 10 min at 2,500 × g
to separate the serum. Alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) enzymatic activities of the
serum were measured with commercial diagnostic kits (Nanjing
Jiancheng Institute of Biotechnology, Nanjing, China).
Measurement of Biochemical Index of
GSH, SOD, CAT, GPx, and MDA
Frozen liver tissues were homogenized in 4◦C PBS and the
homogenate was centrifuged at 2,500 × g at 4◦C for 10 min. The
supernatants were obtained and assayed for malondialdehyde
(MDA), superoxide dismutase (SOD), GSH peroxidase (GPx),
catalase (CAT), and GSH levels using commercially available
assay kits according to the manufacturer’s instructions (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China). Tissue
homogenate was analyzed by protein Bradford assay (Tiangen
Biotech, Beijing, China).
Hepatic UGTs, SULTs, and GST Levels
Measurement
Hepatic profile of UGTs, SULTs, and GST was analyzed using
ELISA kits (Hufeng Biotechnology, Shanghai, China).
Real-Time qPCR Assays
The total mRNA was extracted from the 100 mg of tissue
derived from the lobe of liver sample using a commercially
available kit (Tiangen Biotech, Beijing, China) according to
the manufacturer’s instructions, and reverse-transcribed into
cDNA using HiScriptTM RT SuperMix for qPCR (Vazyme
Biotech, Nanjing, China) with a Veriti Thermal Cycler (Applied
Biosystems, Waltham, United States). Oligonucleotide primers
are listed in Table 1. Real-time qPCR was performed on an iQ5
Real-Time PCR Detection System (Bio-Rad, United States) with
SYBR R© Green Master Mix (Vazyme Biotech, Nanjing, China).
The relative expression of mRNA was expressed by 2−(11Ct) and
normalized to β-actin, an internal control gene.
Western Blot Analysis
Glutamate-cysteine ligase catalytic (GCLC), 3-Nitrotyrosine (3-
NT), Nrf2, and CYP2E1 were detected using total liver protein,
cytosolic and nuclear extracts, and microsome, respectively.
The total liver protein was extracted with 4◦C NP-40 lysis
buffer (Beyotime Institute of Biotechnology, Beijing, China)
containing 1 mM PMSF. Cytosolic and nuclear extracts were
prepared with a commercially available kit according to the
manufacturer’s instructions (Vazyme Biotech, Nanjing, China).
For the microsomal preparation, the liver homogenate was
centrifuged at 9,000 × g for 20 min at 4◦C, and the supernatant
was transferred to a tube with 88 mM CaCl2 at a ratio of 0.4 mL
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per 1 g starting liver tissue; after being shaken on ice for 5 min,
the mixture was centrifuged at 27,000 × g for 20 min. The pellet
was collected and resuspended in 50 mM Tris–HCl mixed with
20% glycerol.
The protein concentration was determined by BCA assay
kit (Beyotime Institute of Biotechnology, Beijing, China).
Equal amounts of extracted protein (50 µg) were separated
on 12% SDS-PAGE, proteins were transferred to a PVDF
membrane, and blocked with TBST containing 5% non-fat milk
for 2 h at room temperature. Subsequently, the membranes
were incubated overnight at 4◦C with primary antibodies
which were 3-NT (dilution 1:1 000. Abcam, Cambridge,
United Kingdom). GCLC (dilution 1:1 000. Abcam, CA,
United Kingdom) CYP2E1 (dilution 1:1 000. Tiangen Biotech,
Beijing, China), Nrf-2 (dilution 1:500. Santa Cruz Biotechnology,
CA, United States), Lamin B (dilution 1:500. Santa Cruz
Biotechnology, CA, United States), and GAPDH (dilution 1:1000.
Tianjin Sungene Biotech, Tianjin, China), and incubated with
secondary antibodies (dilution 1:2 000, Thermo Fisher Scientific,
California, United States) for 2 h at room temperature. Before
analyzing the fold change to control ratio, images of the blots
were visualized by Western Bright ECL (Advansta, California,
United States).
Histological Analysis
The liver tissues were fixed with 4% paraformaldehyde and
embedded into paraffin. Through deparaffinization and
dehydration, the liver samples were sectioned 5 µm and stained
with hematoxylin and eosin (H&E). Then, the periportal areas
were captured by bright field light microscopy (Olympus, Tokyo,
Japan). Five fields in each mouse were randomly chosen. The
histological analysis showed massive necrosis, centrilobular
ballooning degeneration, sinusoidal congestion, and lymphocyte
infiltration of liver lesions.
Statistical Analysis
All the experimental data were expressed as mean ± SD.
The significant differences from the respective controls in all
experiments were assessed by one-way ANOVA using SPSS




As shown in Figure 1, the administration of APAP dramatically
elevated the serum ALT and AST activities levels compared with
the control group. In contrast, in the groups pretreated with 4-
HPA, ALT and AST activities were able to prevent APAP-induced
liver injury. The increase in serum ALT and AST values induced
by APAP was also prevented in the NAC+APAP group.
4 HPA-Alleviated APAP-Induced
Histopathological Changes in the Liver
As shown in Figure 2, normal hepatocytes were arranged in
plates around a central vein and separated by blood sinusoids.
APAP caused hepatocellular injury, markedly massive necrosis,
centrilobular ballooning degeneration, sinusoidal congestion,
and lymphocyte infiltration (marked with arrows). Liver
congestion and centrilobular necrosis were decreased in a
dose-dependent manner by 4-HPA pretreatment. Distinctly, the
groups pre-treated with 25 mg/kg 4-HPA were unscathed and
appeared almost normal, with just a few swollen hepatocytes
observed in the centrilobular zone. A small number of
hepatocytes in the centrilobular region exhibited cytoplasmic
FIGURE 1 | Effects of 4-HPA on APAP-induced increase in serum
transaminases levels. Each value represents the mean ± SD of eight animals
per group. ∗ indicates statistically different group with APAP group (p < 0.05;
AST and ALT, respectively). (1) Control: control group; (2) NAC100+APAP:
treated with 100 mg/kg per day NAC and 300 mg/kg APAP; (3) APAP: a
single dose of 300 mg/kg APAP; (4) 4HPA6+APAP: treated with 6 mg/kg per
day 4-HPA and 300 mg/kg APAP; (5) 4HPA12+APAP: treated with 12 mg/kg
per day 4-HPA and 300 mg/kg APAP; (6) 4HPA25+APAP: treated with
25 mg/kg per day 4-HPA and 300 mg/kg APAP.
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FIGURE 2 | Effects of 4-HPA on hepatic histopathological alterations following
APAP treatment. Typical images were chosen from each experimental group.
Original magnification was 10 × 10 and 40 × 10. The arrows mean liver injury.
vacuolation in the 100 mg/kg NAC pretreated group (marked
with arrows).
4-HPA Inhibited APAP-Induced Oxidative
Liver Stress
The injection of APAP resulted in significantly increased levels
of MDA and depleted GSH levels when compared to the
control, indicating APAP-induced oxidative liver stress. APAP
also decreased the GPx, CAT, and SOD activity levels by 68%,
59%, and 67%, respectively. Administration of NAC prevented
the collapse of the redox balance caused by APAP hepatotoxicity.
In addition, 4-HPA pretreatment significantly prevented all the
effects of APAP in a dose-dependent manner (Figure 3). Relative
to the NAC group, 25 mg/kg 4-HPA pre-treatment was induced
to prevent the CAT and SOD levels.
4-HPA Inhibited APAP-Induced
Nitrotyrosine Adduction
3-Nitrotyrosine formation was 600% higher in APAP groups
compared to the control group (Figure 4B). Pre-administration
of 4-HPA at doses of 6, 12, and 25 mg/kg decreased 3-NT
adduction by 32%, 50%, and 68%, respectively, as compared
to APAP groups. 4-HPA was less effective at increasing GCLC
expression, observed in a dose-dependent manner.
4-HPA Suppressed the Expression of
CYP2E1
According to the data of protein expression and mRNA
levels of CYP2E1 using WB and qPCR, we observed APAP
alone enhanced the levels of CYP2E1 mRNA and protein
levels. Meanwhile, with dose-dependent 4-HPA, CYP2E1 was
significantly suppressed (Figure 5).
4-HPA Enhanced the Protein and mRNA
Levels of Phase II Enzymes
As indicated in Figure 6, Phase II enzyme levels were not affected
by the lowest dose of 4-HPA. SULT levels were mild fluctuations
in the middle dose of 4-HPA. Contextually, compared to APAP
alone, the highest dose of 4-HPA pretreatment caused 25% (GST),
30% (SULT), and 23% (GLUT) up-regulation. At the same time,
similar levels were observed between the positive control group
of NAC+APAP and the 4-HPA25+APAP groups. Overall, 4-HPA
could induce phase II enzyme growth activities in APAP-induced
damage.
A single dose of APAP significantly down-regulated the
hepatic mRNA activities of phase II enzymes versus the control
group. Likewise, 4-HPA pretreatment normalized the mRNA
levels of phase II enzymes in a dose-dependent manner. The 4-
HPA pretreatment at a final dose of 25 mg/kg markedly and
selectively up-regulated the target genes of phase II enzymes
and resulted in higher up-regulation than that of the control
group by 270%, 400%, and 500% or UGT1A1, UGT1A9, and
SULT2A1, respectively. The mRNA levels of UGT1A9 showed
harsh, dose-dependent fluctuations compared to others in 4-HPA
intake groups.
4-HPA Induces Expression of Nrf2 and
Downstream Gene
Nrf2 expression in the livers of mice was examined using
Western blotting and real time-PCR. The protein levels of
nuclear Nrf2 were increased by 170% and 230% in pre-
treated 12 and 25 mg/kg 4-HPA groups, respectively, compared
with the control group. Consistent with protein expression,
mRNA levels displayed the same trend (Figure 7). Nuclear
Nrf2 also showed a slight increase in 4-HPA pre-treatment
groups. Moreover, compared with APAP alone group, 4-HPA
pretreatment groups had a significantly enhanced expression of
GCLC (Figure 4C), which is the target gene of Nrf2 (Figure 7C).
The results clearly demonstrate that 4-HPA stimulated the
translocation of Nrf2 expression to the nucleus in a dose-
dependent manner.
DISCUSSION
Growing evidence suggests that dietary polyphenols could be
a therapy for the prevention of disease and management of
health (Mikell and Khan, 2012). For example, polyphenols can
regulate the expression of drug induced liver injury through the
p38/NF-κB pathway (Liu et al., 2015). However, the polyphenol
was poorly absorbed in the gastrointestinal tract (Chen et al.,
2005). Colonic bacteria can covert polyphenol into a large
number of simple phenolic acids that can be absorbed into the
circulation (Prior et al., 2010), and can exert biological effects
in the body. 4-HPA is the main metabolite of polyphenols by
intestinal microflora Clostridium orbiscinder sp. Nov. (Winter
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FIGURE 3 | Effects of 4-HPA on oxidative stress induced by APAP. (A) GSH, (B) CAT, (C) GPx, (D) SOD (E) MDA. Each value represents the mean ± SD of eight
animals per group. ∗ Above the bars indicate a statistically different group with APAP group (p < 0.05).
FIGURE 4 | Effects of 4-HPA on protein expression of 3-NT and GCLC following APAP overdose. (A) Representative blots of 3-NT, GCLC, and GAPDH expression.
Quantification of 3-NT. (B) GCLC (C) protein levels. ∗ Above the bars indicate statistically a different group with APAP group (p < 0.05). Each value represents the
mean ± SD of eight animals per group.
et al., 1991). The human intestinal bacterium of Clostridium
orbiscinder sp. Nov is capable of cleaving the C-3-C-4 bond of
the quercetin and might be responsible for their pharmacological
effects (Griffiths and Smith, 1972; Moradi-Afrapoli et al., 2016).
The results show that 3,4-HPA and 4-HPA have different binding
sites on CYP2E1 and 3,4-HPA were docked with CYP2E1 in
hydroxyl group (Supplementary Figure S1) and 4-HPA docked
with CYP2E1 in carboxyl group (Supplementary Figure S2).
The interaction of 4-HPA was comparatively higher than the
3,4- HPA. In the present study suggested that 4-HPA may
use potential drug candidate for the hepatocellular carcinoma.
This study, which primarily focuses on the effect of 4-HPA on
acute acetaminophen toxicity in mice, investigates the health
implications of metabolic phenolic acids. AST and ALT are
secreted into the bloodstream and are sensitive biomarkers
used in the evaluation of hepatotoxicity (Waters et al., 2001;
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FIGURE 5 | Effects of 4-HPA on protein and mRNA expression of CYP2E1 following APAP overdose. (A) Representative blots of CYP2E1 and GAPDH expression.
(B) Quantification of CYP2E1 protein levels. (C) Relative mRNA levels of CYP2E1. Each value represents the mean ± SD of eight animals per group. ∗ Above the
bars indicate a statistically different group with APAP group (p < 0.05).
FIGURE 6 | Effects of 4-HPA on mRNA and levels of phase II enzymes following APAP overdose. The levels of GST (A), UGTs (B), and SULTs (C) were determined
by ELISA, and the mRNA levels of GSTa1 and GSTm1 (D), UGT1A1, UGT1A6 and UGT1A9 (E), SULT1A1 and SULT2A1 (F) were determined by real time PCR.
Each value represents the mean ± SD of eight animals per group. ∗ Above the bars indicate a statistically different group with APAP group (p < 0.05).
Jiang et al., 2016). In this study, we have observed hepatic
histopathological lesions and high levels of ALT and AST in
the serum of APAP-induced mice compared with the control
group. The data show that 4-HPA pretreatment alleviates these
alters in a dose-dependent manner, indicating the protective
ability of 4-HPA to prevent APAP-induced injury to the
liver.
Using the model of APAP-treated mice, hepatic dysfunction is
majorly caused by oxidative stress. APAP could be metabolized
by CYP2E1 enzymes into NAPQI, which undergoes chemical
and enzymatic conjugation to GSH in APAP toxicity (Michael
Brown et al., 2012). This could lead to lipid peroxidation,
nitrated proteins (Hinson et al., 2000), and subsequent tissue
damage. It has been demonstrated that antioxidant enzyme
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FIGURE 7 | 4-HPA induces expression of Nrf2. (A) Western blots of Nrf2, Lamin B, and GAPDH expression. (B) Nuclear Nrf2/Cytosolic Nrf2 content ratios and the
densities of nuclear and cytosolic Nrf2 normalized by Lamin B and GAPDH. (C) Relative mRNA levels of Nrf2. Each value represents the mean ± SD of eight animals
per group. ∗ Above the bars indicate a statistically different group with the APAP group (p < 0.05).
FIGURE 8 | A summary of 4-HPA’s effects on the APAP-induced injury. 4-HPA may stimulate the Nrf2/Keap1 into phosphorylated Nrf2 by MAPK, P13, ERK or JNK.
In the nuclear, the phosphorylated Nrf2 combines with one of small Maf proteins and binds to the antioxidant response element (ARE) in the upstream promoter
region of many antioxidative genes and phase II enzymes, and initiates their transcription. 4-HPA promotes the APAP transformation into a non-toxic form. 4-HPA
increased Nrf-2 translocation to the nucleus and enhanced the activity of phase II enzymes and anti-oxidant enzymes, and could thereby ameliorate APAP-induced
liver injury. It can inhibit the activity of CYP2E1, alleviate the oxidative stress of the liver, and counter the liver toxicity induced by APAP. The red arrows marks
indicated that the results of 4-HPA treatments.
activities could be reduced by APAP overdose, and some
treatments have been tested to recover enzymatic function
(Carvalho et al., 2013). Here, APAP depleted hepatic GSH,
enhanced MDA concentrations, and massively increased 3-NT
protein adduction, which are indicators of oxidative stress, along
with lowered GPx, SOD, and CAT concentration. The mice
that were pretreated with 4-HPA normalized the concentration
of antioxidant enzymes and returned MDA levels to normal.
The data indicate antioxidant enzymes, especially CAT, as key
protective actions induced by 4-HPA against APAP-induced liver
injury. It was demonstrated that APAP caused the increase of
CYP2E1 expression in the liver. 4-HPA markedly suppressed
the levels of CYP2E1 expression and enhanced the antioxidant
enzyme levels, which may be due to the powerful antioxidant,
suggesting a potential antioxidative effect associated with 4-
HPA. UGT, SULT, and GST catalyzed metabolism, making a
high contribution to APAP clearance (Ansher et al., 1983;
Fakurazi et al., 2012), and then formed urinary acetaminophen
mercapturates. In this study, seven kinds of the gene, which
are major enzymes and primary isoforms of UGTs, SULTs,
and GST, were involved in the detoxification of APAP. This
research clarifies that phase II enzyme protein and mRNA
expression were increased by 4-HPA in a dose-dependent
manner. Meanwhile, 4-HPA markedly enhanced the mRNA
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levels of UGT1A9 and SULT2A1. The activity of the UGTs,
SULTs, GST, and CYP2E1 were not tested in this study. These
measures are relevant and should be further assessed to validate
one of the hypotheses that 4-HPA attenuates the APAP-induced
oxidative stress by the findings of the present study. These results
show that the regulation of phase II enzymes is likely to join
in the mechanism for functional changes by 4-HPA in this
study.
Phase II enzymes are essential for inducing gene expression by
Nrf2. The importance of Nrf2 is evident from reports showing
that the levels of phase II gene are significantly reduced in
Nrf2-deficient mice and that the induction of phase II genes is
abolished by the Nrf2 disruption. (Kalthoff et al., 2010; Gum
and Cho, 2013). One of the reasons is that ARE is a cis-
acting DNA response sequence located in the regulatory regions
of phase II genes with the consensus of TGAG/CNNNGC (N
represents any base). APAP undergoes phase II detoxification
pathways in the liver; about 85% of APAP is recovered as
APAP-gluc and APAP-sulf by hepatic phase II conjugation
enzymes, including UGTs and SULTs. As the result shows,
4-HPA significantly increased the levels of SULTs and UGTs
in Figure 6. Moreover, some reports have demonstrated that
Nrf2-null mice displayed higher susceptibility to APAP-induced
liver injury, indicating that the Nrf2 battery serves as a target
of hepatoprotection (Okawa et al., 2006; Klaassen and Reisman,
2010). Nrf2, a Cap’n’collar/basic leucine zipper (CNC-bZIP)
families of proteins, is regarded as the master regulator of
oxidant defense. The pretreatment of mice with 4-HPA induces
up-regulation of nuclear Nrf2 expression and mRNA levels
in a dose-dependent manner. Lin et al. (2015) found that
GCLC expression linked with activation of Nrf2 signaling by
knockdown of Nrf2 in HepG2 cells. Furthermore, GCLC, a
rate-limiting enzyme, is a major antioxidant molecule in the
synthesis of GSH. 4-HPA increases protein expression of GCLC,
which is a downstream gene of Nrf2, resulting in enhanced
GSH levels. These results suggest that Nrf2 is involved in
detoxification and antioxidant signaling pathways induced by
4-HPA.
Previous studies have shown that phenolic acids directly
scavenge free radicals or indirectly increase endogenous
cellular antioxidant defenses, via the activation of Nrf2
transcription factor pathways (Kelsey et al., 2010). We have
determined that 4-HPA is a poor scavenger of free radicals
using a common method of the radical 2,2-diphenyl-1-
picrylhydrazyl (DPPH) test (data not shown). Combined
with the existing results, 4-HPA may have potential utility in
mitigating oxidative stress and inducing Nrf2 transcriptional
expression.
In this study, the ability of 4-HPA in reducing liver
dysfunction was evaluated and compared to the NAC under
APAP-induced ALF. 4-HPA was more effective at a lower dose
than NAC. It is worthy to mention that APAP hepatotoxicity
was enhanced following pretreatment with 4-HPA for 3 days
at a dose of 50 mg/kg and 100 mg/kg, in our preliminary
experiments. The sizes of doses of polyphenols determine
the primary site of metabolism. Particularly, large doses are
metabolized primarily in the liver (Bell et al., 2000). Moreover,
different concentrations of phenolic acids could be involved
in cellular functions and mitochondrial failure (Li et al., 2004;
Fedotcheva et al., 2008). The concentration of endogenous
circulating p-hydroxyphenylacetate in rat plasma is considerably
higher, 410 ng/mL or 2.7 mol/L (Mani et al., 2003). The data of the
present study considered that 4-HPA can prevent APAP induced
liver injury through two pathways, the first way is 4-HPA down-
regulated the expression of CYP2E1, which decreased plasma
concentration of APAP into NAPQI; the second way is 4-HPA
up-regulated the expression of detoxiciation pathway, it can
stimulate Nrf2 translocation from cytoplasm into mitochondria,
activate Nrf2 and thus increased the activity of antioxidant
enzyme (SOD, GSH, CAT, GPx) and Phase II enzymes (GST,
SULTs, and UGTs), increased expression of antioxidant genes
clear APAP metabolite ROS and the increased expression of
Phase II enzymes accelerated metabolism APAP in a non-
toxic way, which decreased plasma concentration of APAP
and accelerated APAP harmless metabolism (Figure 8). In this
study, a pretreatment protocol was used to evaluate preventive
properties; however, the curative action is not guaranteed
by the article; the therapeutic effect of drug liver injury by
4-HPA should be further researched. In summary, 4-HPA, as a
microbial metabolite of polyphenol, has a beneficial influence
on the detoxification of APAP and is associated with the
inhibited activity of CYP2E1 and the up-regulation of antioxidant
enzymes and phase II enzymes via Nrf2 activation. 4-HPA
could be a promising strategy for preventing drug-induced
hepatotoxicity.
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